Chinese herbal medicine as adjuvant treatment to chemotherapy for multidrug-resistant tuberculosis (MDR-TB): A systematic review of randomised clinical trials

Tuberculosis

Volumn 95, Issue 4, 2015, Pages 364-372

  Wang, Mei ^a,b   Guan, Xin ^c   Chi, Yuan ^b   Robinson, Nicola ^d   Liu, Jian Ping ^a,b  

^a BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b LIAONING UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^c CHINA MEDICAL UNIVERSITY   (China)

^d LONDON SOUTH BANK UNIVERSITY   (United Kingdom)

Author keywords

Chinese herbal medicine; Meta analysis; Multidrug resistant tuberculosis; Randomised clinical trials; Systematic review

Indexed keywords

AMIKACIN; AMINOSALICYLIC ACID; ASTRAGALUS EXTRACT; BAIHE GUJIN; BAOZHEN; BUJIN; CHINESE DRUG; CYCLOSERINE; ETHAMBUTOL; FEIFU; FEIJIEHE; FUZHENG KANGLAO; ISONIAZID; JIEHE; KANAMYCIN; KANGLAO; PASINIAZID; PLACEBO; PROTIONAMIDE; PYRAZINAMIDE; QIBAIHE; QINBU TONGLUO; RIFAMPICIN; RUNFEI; SHENHA; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG; UNINDEXED DRUG; YANGYIN RUNFEI; YIFEI TONGLUO; YIFEI XIEDING; HERBACEOUS AGENT;

ADJUVANT THERAPY; ARTICLE; EXTENSIVELY DRUG RESISTANT TUBERCULOSIS; GASTROINTESTINAL SYMPTOM; HUMAN; KIDNEY DYSFUNCTION; LIVER DISEASE; LIVER FUNCTION; LUNG CAVITY; LUNG LESION; META ANALYSIS; MULTIDRUG RESISTANT TUBERCULOSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RASH; SPUTUM ANALYSIS; SYSTEMATIC REVIEW; CHI SQUARE DISTRIBUTION; DRUG COMBINATION; DRUG EFFECTS; ISOLATION AND PURIFICATION; LUNG; MICROBIOLOGY; MYCOBACTERIUM TUBERCULOSIS; ODDS RATIO; RISK FACTOR; SPUTUM; TIME; TREATMENT OUTCOME; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY;

ANTITUBERCULAR AGENTS; CHI-SQUARE DISTRIBUTION; DRUG THERAPY, COMBINATION; DRUGS, CHINESE HERBAL; HUMANS; LUNG; MYCOBACTERIUM TUBERCULOSIS; ODDS RATIO; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; SPUTUM; TIME FACTORS; TREATMENT OUTCOME; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY;

EID: 84931561191     PISSN: 14729792     EISSN: 1873281X     Source Type: Journal    
DOI: 10.1016/j.tube.2015.03.003     Document Type: Review

References (52)

1. World Health Organization Global tuberculosis reports 2013 2012 WHO Geneva, Switzerland
2. N.D. Prihoda, O.V. Arjanova, L.V. Yurchenoko, N.I. Sokolenko, L.A. Vihrova, and V.S. Pylypchuk Open label trial of adjuvant immunotherapy with Dzherelo, Svitanok and Lizorm, in MDR-TB, XDR-TB and TB/HIV co-infected patients receiving anti-tuberculosis therapy under DOT J Med Plant Res 1 2007 117 122
3. D.V. Havlir, H. Getahun, I. Sanne, and P. Nunn Drug-resistant tuberculosis: emerging treatment options JAMA 300 2008 423 430
4. A.K. Kakkar, and N. Dahiya Bedaquiline for the treatment of resistant tuberculosis: promises and pitfalls Tuberculosis 94 2014 357 362 (Edinb)
5. A. Shehzad, G. Rehman, M. Ul-Islam, W.A. Khattak, and Y.S. Lee Challenges in the development of drugs for the treatment of tuberculosis Braz J Infect Dis 17 2013 74 81
6. J. Spinks, D. Johnston, and B. Hollingsworth Complementary and alternative medicine (CAM) use and quality of life in people with type 2 diabetes and/or cardiovascular disease Complement Ther Med 22 2014 107 115
7. E. McCarthy, and J.M. O'Mahony What's in a name? Can Mullein Weed beat TB where modern drugs are failing? Evid Based Complement Altern Med 2011 2011 7 10.1155/2011/239237
8. A. Jiménez-Arellanes, R. León-Díaz, M. Meckes, A. Tapia, G.M. Molina-Salinas, and J. Luna-Herrera Antiprotozoal and antimycobacterial activities of pure compounds from Aristolochia elegans rhizomes Evid Based Complement Altern Med 2012 2012 7 10.1155/2012/593403
9. I.O. Lawal, D.S. Grierson, and A.J. Afolayan Phytotherapeutic information on plants used for the treatment of tuberculosis in eastern cape province, South Africa Evid Based Complement Altern Med 2014 2014 11 10.1155/2014/735423
10. C.A. Gray, J.A. Johnson, and D. Webster Canadian traditionally used medicinal plants: can they play a role in antituberculosis drug development? Future Med Chem 5 2013 853 855
11. The State Pharmacopoeia Commission of the People's Republic of China Pharmacopoeia of the People's Republic of China 2005 2005 China Chemical Industry Press Beijing, China
12. D. Moher, A. Liberati, J. Tetzlaff, and D.G. Altman PRISMA Group. Preferred Reporting Items for Systematic Reviews and meta-analyses: the PRISMA statement Ann Intern Med 151 2009 264 269
13. K.F. Laserson, L.E. Thorpe, V. Leimane, K. Weyer, C.D. Mitnick, V. Riekstina, E. Zarovska, M.L. Rich, H.S. Fraser, E. Alarcón, J.P. Cegielski, M. Grzemska, R. Gupta, and M. Espinal Speaking the same language: treatment outcome definitions for multidrug-resistant tuberculosis Int J Tuberc Lung Dis 9 2005 640 645
14. J.P.T. Higgins, and S. Green Cochrane handbook for systematic reviews of interventions. Cochrane Collaboration, Version 5.1.0 2011 http://handbook.cochrane.org
15. Q.S. Cai, H.Y. Ma, and W.M. Ding The effect of astragalus on T lymphocyte subpopulations in treating patients with multi-drug resistant pulmonary tuberculosis Chin J Prim Med Pharm 7 2000 209 210
16. W.J. Feng, Y.K. Liu, F. He, C.Q. Liu, Z.Z. Ye, and Z.J. Fu Short-term therapeutic effect of Yifei Tongluo decoction combined with chemotherapy for multidrug-resistant tuberculosis J New Chin Med 44 2012 22 25
17. W.J. Feng, Y.K. Liu, F. He, C.Q. Liu, Z.Z. Ye, and Z.J. Fu A multicenter middle-term clinical effect observation of Yifei Tongluo prescription combined with chemotherapy on the treatment of multi-drug resistant tuberculosis J Hunan Univ Chin Med 34 2014 46 50
18. Y. Jiang, Xin Li, Z.Y. Yu, H.Y. Yin, and Y.Q. Han Clinical study of drug resistant pulmonary tuberculosis treated by combination of anti-tuberculosis chemicals and compound Astragalus Capsule Chin J Integr Med 10 2004 102 106
19. D. Li, D.B. Du, C.Q. Xiao, Y.L. Chen, Z.J. Chen, and Z. Jin Clinical efficacy of Jie-he-wan as adjuvantive therapy for the MDR-TB and their effects on immunological functions Chin J Mod Med 23 2013 70 74
20. F. Li, M.R. Zuo, and W.G. He Clinical analysis of traditional Chinese combined western medicine treatment of multi-drug resistant tuberculosis Guide China Med 11 2013 1 2 13
21. F.J. Li, M. Zhou, Y.F. Cui, and F. Li Effects of Qibai mixture on the immune function of tuberculosis patients who are resisted to multi-drugs Zhejiang J Integr Tradit Chin West Med 19 2009 137 139
22. Y. Li The observation of the clinical efficacy of Baihe Gujin Tang in treatment of MDR-TB In Dissertation for Master Degree of Liaoning University of Chinese medicine 2011
23. C.Z. Lin, X.H. Zhu, J.Q. Pang, and K. Deng Clinical immunology research of integrated Chinese and western medicine treating for multidrug-resistant tuberculosis Chin J Clin 4 2010 1049 1051 (Electronic Edition)
24. J.Q. Lu, and B. Gao 32 cases of No.1 Fuzheng Kanglao powder treating for multidrug-resistant tuberculosis Shanxi J Tradit Chin Med 35 2014 314 315
25. Z.H. Lu, H.Y. Zhang, P.H. Geng, X.Y. Guo, Z.S. Zhang, and H.P. Xiao Clinical study on TCM syndrome identification and chemotherapy for 388 cases of multidrug-resistant pulmonary tuberculosis J TCM 55 2014 1469 1474
26. G.R. Ma, X.H. Zhang, Y.C. Hao, and L.L. Zhang Clinical efficacy observation of 208 multidrug-resistant tuberculosis patients treated by Chinese herbal medicine combined with chemotherapy Chin J Ethnomed Ethnopharmacy 17 2009 110 111
27. C.L. Ouyang Observation of the efficacy of integrated Chinese and western medicine treating multidrug-resistant tuberculosis Asia-pacific Tradit Med 9 2013 107 108
28. Y. Pei, and Z.Y. Huang Western and traditional Chinese medicine syndrome differentiation and treatment of long-range plan of 39 cases of multi drug resistant pulmonary tuberculosis Chin Med Her 10 2013 119 122
29. Y. Pei, M.J. Huang, and L.H. Fan Clinical study on scutellaria-stemonae network vessels freeing formula for MDR-PTB in immune function Guid J TCM Pharm 8 2014 22 24
30. M.Y. Qu, Z. Jiang, W.J. Feng, and X.Y. Yang Clinical research of the effect of Kanglao decoction in treatment of multi-drug resistance tuberculosis (MDR-TB) Chin J Mod Med 24 2014 91 94
31. F.Y. Sun The clinical research of integrated traditional and western medicine treating for multidrug-resistant tuberculosis World Health Dig 9 2012 185 186
32. Y.P. Sun, Q.S. Cai, L.S. Yin, and P.C. Wang Self-made Runfei decoction combined with western medicine on efficacy and immune function of resistant tuberculosis patients Chin Arch Tradit Chin Med 32 2014 1167 1169
33. F.J. Tong Traditional and western medicine treatment for MDR-TB in 25 cases J Pract Tradit Chin Inter Med 24 2010 73 74
34. J. Wan Observation the efficacy of treatment regimen including Bujin tablet for multidrug resistant tuberculosis Youjiang Med 30 2002 423
35. P.C. Wang, and F.J. Li Clinical observation the CHM improvement the adverse events of anti-tuberculosis drugs for multidrug resistant tuberculosis Zhejiang J Integr Tradit Chin West Med 21 2011 231 232
36. Z.Y. Wang, and S.Y. Li Clinical efficacy observation of 70 multidrug-resistant tuberculosis patients treated by integrated Chinese and western medicine Chin J Esthet Med 20 2011 405
37. J. Xiao Clinical study of combining Chinese medicine with chemical medicine on multidrug resistant tuberculosis J TCM Univ Hunan 28 2008 60 61
38. J. Zhang, Y. Zhang, H.W. Liang, S.Q. Li, L.J. Liang, and J.J. Mao Clinical research of Yiqi Yangyin decoction adjuvantive to treat MDR-TB J Clin Pulm Med 16 2011 1459 1460
39. X.Y. Zhang, H.Y. An, Y.F. Zhang, and Y.H. Ma Clinical research of Jieheling treating for multidrug-resistant tuberculosis J Heze Med Coll 22 2010 31 34
40. Z.J. Zhang, and Y.W. Zhou Clinical observation on treating drug-resistant pulmonary tuberculosis J Clin Pulm 16 2011 1546 1547
41. B.T. Zhong Observation the clinical efficacy of Huangqi injection treating for multidrug resistant tuberculosis Zhejiang J Integr Tradit Chin West Med 14 2004 83 84
42. L.X. Zhou, J.P. Huang, and M. Luo Clinical study of combining Chinese medicine with chemical medicine on MDR-TB Chin Arch Tradit Chin Med 31 2013 942 945
43. L.X. Zhou, J.P. Huang, and H.F. Fan Clinical research of the treatment of multidrug resistant tuberculosis Chin J Gen Pract 12 2014 322 323
44. Y.M. Zhang, Zh Lu, X.Y. Guo, H.H. Xue, P.H. Geng, and H.Y. Zhang Combination of replenishing qi to nourish yin method, eliminating blood stasis method with chemotherapy in the treatment of multi-drug resistant pulmonary tuberculosis: a randomized controlled trial Shanghai J TCM 46 2012 44 60
45. H.D. Xu, C.G. You, R.L. Zhang, P. Gao, and Z.R. Wang Effects of Astragalus polysaccharides and astragalosides on the phagocytosis of Mycobacterium tuberculosis by macrophages J Int Med Res 35 2007 84 90
46. L.X. Wang, Y.Y. Wu, and Y. Wang Effect of Qibudan on expression of TLR2 in tuberculosis infection Chin Pharmacol Bull 27 2011 1284 1287
47. K.J. Zhao, S.L. Liu, and H.M. Li Inhibiting effects of different extracts and constituents from Euphorbia fisheriana on tuberculosis bacillus Chin Pharmac 10 2007 1063 1065
48. X.Q. Li, S.S. Chen, S.L. Liu, and H.M. Li The inhibiting effects of Euphorbia fisheriana on tuberculous bacillus Pharm J Chin PLA 22 2006 153 155
49. K. Jain, M. Desai, R. Solanki, and R.K. Dikshit Treatment outcome of standardized regimen in patients with multidrug resistant tuberculosis J Pharmacol Pharmacother 5 2014 145 149
50. S.D. Ahuja, D. Ashkin, M. Avendano, R. Banerjee, M. Bauer, and J.N. Bayona Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9153 patients PloS Med 9 2012 e1001300
51. K.F. Schulz, D.G. Altman, D. Moher CONSORT Group CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials Ann Intern Med 152 2010 726 732
52. J.J. Gagnier, H. Boon, P. Rochon, D. Moher, J. Barnes, and C. Bombardier CONSORT Group. Reporting randomized, controlled trials of herbal interventions: an elaborated CONSORT statement Ann Intern Med 144 2006 364 367